 model prostatic carcinoma tumor kinetics prostate specific antigen levels radiation therapy Serial prostatic specific antigen values PSA patients definitive radiation therapy localized adenocarcinoma prostate PSA patients None patients metastases PSA patients rate decline similar rate rise patients patients distant metastases years treatment PSA values radiation therapy model tumor kinetics model mean duration parameter development distant metastases years treatment patients low risk relapse mean weeks high risk relapse